(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are Moderna, Aspen Group, and Cintas Corporation.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Moderna (MRNA) 278.80 7.36% 2021-07-16 07:12:14
2 Aspen Group (ASPU) 6.20 4.55% 2021-07-16 07:11:23
3 Cintas Corporation (CTAS) 385.00 4.29% 2021-07-16 07:07:57
4 AMC (AMC) 37.52 4.22% 2021-07-16 07:13:30
5 Redfin (RDFN) 57.00 2.89% 2021-07-16 07:12:34
6 Intuitive Surgical (ISRG) 976.20 2.36% 2021-07-16 07:09:20
7 Match Group (MTCH) 165.99 1.94% 2021-07-16 07:12:16
8 Bionano Genomics (BNGO) 5.95 1.88% 2021-07-16 07:11:31
9 MicroVision (MVIS) 14.00 1.74% 2021-07-16 07:09:45
10 Zoom (ZM) 363.00 1.73% 2021-07-16 07:13:14

The three most active and biggest losers today are FibroGen, Catalyst Pharmaceuticals, and ZoomInfo.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 FibroGen (FGEN) 16.50 -33.57% 2021-07-16 07:08:26
2 Catalyst Pharmaceuticals (CPRX) 5.20 -5.8% 2021-07-16 07:07:50
3 ZoomInfo (ZI) 47.00 -5.53% 2021-07-16 07:13:12
4 ImmunoGen (IMGN) 5.64 -3.09% 2021-07-16 07:09:10
5 Arcelor Mittal (MT) 30.44 -2.28% 2021-07-16 07:15:59
6 Canaan (CAN) 6.16 -2.22% 2021-07-16 07:11:37
7 Rio Tinto (RIO) 84.64 -1.87% 2021-07-16 07:16:25
8 Riot Blockchain (RIOT) 27.75 -1.67% 2021-07-16 07:12:36
9 The Hershey Company (HSY) 176.65 -1.58% 2021-07-16 06:54:06
10 Sun Communities (SUI) 180.00 -1.54% 2021-07-16 06:55:34

Most Active Premarket Winners today

1. Moderna (MRNA) – Premarket: 7.36%

NASDAQ Composite ended the session with Moderna jumping 5.28% to $259.68 on Friday, following the last session’s upward trend. NASDAQ Composite fell 0.7% to $14,543.13, after three successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Moderna is 14222900, 52.47% above its average volume of 9328070.

Moderna’s last close was $246.66, 1.14% under its 52-week high of $249.50.

News about Moderna today

U.S. to send 3.5 million doses of Moderna vaccine to Argentina. According to today’s article on Bloomberg Quint, "The U.S. will send 3.5 million Moderna Inc. vaccines to Argentina on Friday as part of growing donations from President Joe Biden’s administration to developing nations across Latin America, Asia and Africa.", "This donation is part of a pledge by the Biden administration to ship at least 80 million doses of shots produced by Pfizer Inc., Moderna and Johnson & Johnson."

Moderna’s Sales

Moderna’s sales growth is 6347.1% for the present quarter and 7189.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 2048.4% and 1439%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 24112.5%, now sitting on 2.73B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current volatility was 2.57%, 0.77%, and 3.03%, respectively.

Moderna’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.57% (last week), 2.55% (last month), and 3.03% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be oversold (<=20).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $259.68 at 08:34 EST, above its 52-week high of $249.50.

Moderna’s Moving Average

Moderna’s value is way above its 50-day moving average of $212.36 and way above its 200-day moving average of $164.74.

Previous days news about Moderna

U.S. sending 1.5 million doses of Moderna vaccine to Sri Lanka. According to Bloomberg Quint on Wednesday, 14 July, "The U.S. is sending more than 1.5 million doses of Moderna Inc.’s coronavirus vaccine to Sri Lanka on Wednesday, the latest shipment as President Joe Biden begins sharing the American stockpile of shots abroad."

Moderna climbs as S&P 500 set to welcome covid vaccine maker. According to Bloomberg Quint on Thursday, 15 July, "Shares of Moderna have more than tripled over the past 12 months, sending the Cambridge, Massachusetts-based company’s market value above $100 billion for the first time this week. "

More news about Moderna.

2. Aspen Group (ASPU) – Premarket: 4.55%

NASDAQ Composite ended the session with Aspen Group rising 0.68% to $5.93 on Friday, after two successive sessions in a row of losses. NASDAQ Composite slid 0.7% to $14,543.13, after three sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Volume

Today’s last reported volume for Aspen Group is 187184, 38.95% below its average volume of 306590.

Aspen Group’s last close was $5.89, 55.24% under its 52-week high of $13.16.

Aspen Group’s Revenue

Year-on-year quarterly revenue growth grew by 32.6%, now sitting on 62.84M for the twelve trailing months.

Volatility

Aspen Group’s last week, last month’s, and last quarter’s current volatility was a negative 3.32%, a positive 0.18%, and a positive 2.87%, respectively.

Aspen Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.89% (last week), 3.79% (last month), and 2.87% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Aspen Group’s stock is considered to be overbought (>=80).

Aspen Group’s Stock Yearly Top and Bottom Value

Aspen Group’s stock is valued at $5.93 at 08:34 EST, way under its 52-week high of $13.16 and way higher than its 52-week low of $4.70.

Aspen Group’s Moving Average

Aspen Group’s value is under its 50-day moving average of $6.26 and way under its 200-day moving average of $7.37.

More news about Aspen Group.

3. Cintas Corporation (CTAS) – Premarket: 4.29%

NASDAQ Composite ended the session with Cintas Corporation dropping 2.59% to $369.15 on Friday, after two successive sessions in a row of losses. NASDAQ Composite dropped 0.7% to $14,543.13, after three successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Cintas Corporation is 1140870, 181.86% above its average volume of 404765.

Cintas Corporation’s last close was $378.95, 3.39% below its 52-week high of $392.25.

The company’s growth estimates for the present quarter is 70.4% and a drop 0.4% for the next.

Cintas Corporation’s Revenue

Year-on-year quarterly revenue growth declined by 1.9%, now sitting on 6.9B for the twelve trailing months.

Volatility

Cintas Corporation’s last week, last month’s, and last quarter’s current volatility was 0.21%, 0.55%, and 0.99%, respectively.

Cintas Corporation’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.70% (last week), 0.93% (last month), and 0.99% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cintas Corporation’s stock is considered to be overbought (>=80).

Cintas Corporation’s Stock Yearly Top and Bottom Value

Cintas Corporation’s stock is valued at $369.15 at 08:34 EST, under its 52-week high of $392.25 and way higher than its 52-week low of $274.55.

Cintas Corporation’s Moving Average

Cintas Corporation’s value is higher than its 50-day moving average of $367.00 and higher than its 200-day moving average of $349.28.

More news about Cintas Corporation.

4. AMC (AMC) – Premarket: 4.22%

NYSE Composite ended the session with AMC jumping 7.69% to $36.00 on Friday, after four sequential sessions in a row of losses. NYSE Composite dropped 0.27% to $16,499.06, after three sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for AMC is 189506000, 16.75% above its average volume of 162317000.

AMC’s last close was $33.43, 53.97% below its 52-week high of $72.62.

The company’s growth estimates for the current quarter and the next is 82.7% and 93.6%, respectively.

AMC’s Revenue

Year-on-year quarterly revenue growth declined by 84.2%, now sitting on 449.2M for the twelve trailing months.

Volatility

AMC’s last week, last month’s, and last quarter’s current volatility was a negative 6.82%, a negative 2.20%, and a positive 7.35%, respectively.

AMC’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.82% (last week), 5.25% (last month), and 7.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AMC’s stock is considered to be overbought (>=80).

AMC’s Stock Yearly Top and Bottom Value

AMC’s stock is valued at $36.00 at 08:34 EST, way under its 52-week high of $72.62 and way above its 52-week low of $1.91.

AMC’s Moving Average

AMC’s value is way below its 50-day moving average of $46.03 and way above its 200-day moving average of $17.33.

Previous days news about AMC

Why AMC entertainment stock is falling again today. According to The Motley Fool on Tuesday, 13 July, "They might limp along, and with AMC being the biggest chain, it could outlast others. ", "Now AMC Entertainment will have to scrounge among its seat cushions to find money to continue operating amid weak attendance numbers."

AMC share price gets cut in half as reality sets in for meme stock investors. According to CNBC on Wednesday, 14 July, "Still, AMC is heavily leveraged with $4.5 billion of net debt and deferred rent at year-end, according to an estimate from Loop Capital Markets.", "None of the Wall Street analysts covering AMC and GameStop have a buy rating on the stocks, according to FactSet."

AMC share price: the bottom falls out as meme stocks hit new lows. According to FXStreet on Thursday, 15 July, "Shares of AMC crashed again on Wednesday, as the meme stock fell by 15.04% and closed the trading day at $33.43. ", "Of course, had AMC raised that capital it would have been able to pay off most of its debts, and the move looks worse this week now that the stock price has been cut in half."

AMC share price: support breaks as AMC officially is in free fall. According to FXStreet on Wednesday, 14 July, "Despite this, shares of AMC fell on Monday and Tuesday, signalling that even the global reopening at the ticket booth may not be able to save AMC’s stock from remaining overvalued and uber inflated. "

Amc, gamestop swoon as meme stocks run out of air. According to The Wall Street Journal on Thursday, 15 July, "Coordinated trades on Reddit forums, with buyers encouraging each other to plow money into certain stocks, helped GameStop shoot up over 750% this year, while AMC is up more than 1470%. ", "At the start of the year, GameStop was trading at less than $20 apiece, while AMC was priced at roughly $2. "

More news about AMC.

5. Redfin (RDFN) – Premarket: 2.89%

NASDAQ Composite ended the session with Redfin rising 0.98% to $55.40 on Friday while NASDAQ Composite dropped 0.7% to $14,543.13.

Volume

Today’s last reported volume for Redfin is 992816, 33.4% below its average volume of 1490780.

Redfin’s last close was $54.86, 44.27% below its 52-week high of $98.44.

The company’s growth estimates for the present quarter and the next is a negative 312.5% and a negative 90%, respectively.

Redfin’s Revenue

Year-on-year quarterly revenue growth grew by 4.9%, now sitting on 886.09M for the twelve trailing months.

Volatility

Redfin’s last week, last month’s, and last quarter’s current volatility was a negative 0.67%, a negative 0.04%, and a positive 2.90%, respectively.

Redfin’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.77% (last week), 2.00% (last month), and 2.90% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Redfin’s stock is considered to be overbought (>=80).

Redfin’s Stock Yearly Top and Bottom Value

Redfin’s stock is valued at $55.40 at 08:34 EST, way under its 52-week high of $98.44 and way above its 52-week low of $36.05.

Redfin’s Moving Average

Redfin’s value is below its 50-day moving average of $60.46 and way below its 200-day moving average of $68.25.

More news about Redfin.

6. Intuitive Surgical (ISRG) – Premarket: 2.36%

NASDAQ Composite ended the session with Intuitive Surgical falling 0.15% to $953.66 on Friday while NASDAQ Composite slid 0.7% to $14,543.13.

Volume

Today’s last reported volume for Intuitive Surgical is 433574, 19.69% below its average volume of 539879.

Intuitive Surgical’s last close was $955.08, 1.03% under its 52-week high of $965.05.

Intuitive Surgical’s Sales

Intuitive Surgical’s sales growth is 48.3% for the ongoing quarter and 34.7% for the next. The company’s growth estimates for the present quarter and the next is 175.7% and 15.5%, respectively.

Intuitive Surgical’s Revenue

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 4.55B for the twelve trailing months.

Volatility

Intuitive Surgical’s last week, last month’s, and last quarter’s current volatility was 0.15%, 0.50%, and 1.13%, respectively.

Intuitive Surgical’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.43% (last week), 0.65% (last month), and 1.13% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Intuitive Surgical’s stock is considered to be overbought (>=80).

Intuitive Surgical’s Stock Yearly Top and Bottom Value

Intuitive Surgical’s stock is valued at $953.66 at 08:34 EST, below its 52-week high of $965.05 and way higher than its 52-week low of $596.36.

Intuitive Surgical’s Moving Average

Intuitive Surgical’s worth is higher than its 50-day moving average of $889.38 and way higher than its 200-day moving average of $809.17.

More news about Intuitive Surgical.

7. Match Group (MTCH) – Premarket: 1.94%

NASDAQ Composite ended the session with Match Group jumping 0.8% to $162.83 on Friday, following the last session’s downward trend. NASDAQ Composite dropped 0.7% to $14,543.13, after three successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Match Group is 2123440, 6.63% above its average volume of 1991470.

Match Group’s last close was $161.53, 7.53% below its 52-week high of $174.68.

The company’s growth estimates for the current quarter and the next is 59.4% and 26.1%, respectively.

Match Group’s Revenue

Year-on-year quarterly revenue growth grew by 22.6%, now sitting on 2.51B for the twelve trailing months.

Volatility

Match Group’s last week, last month’s, and last quarter’s current volatility was 1.09%, 0.66%, and 1.88%, respectively.

Match Group’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.09% (last week), 1.39% (last month), and 1.88% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Match Group’s stock is considered to be overbought (>=80).

Match Group’s Stock Yearly Top and Bottom Value

Match Group’s stock is valued at $162.83 at 08:34 EST, below its 52-week high of $174.68 and way higher than its 52-week low of $87.56.

Match Group’s Moving Average

Match Group’s worth is above its 50-day moving average of $151.57 and above its 200-day moving average of $149.20.

More news about Match Group.

8. Bionano Genomics (BNGO) – Premarket: 1.88%

NASDAQ Composite ended the session with Bionano Genomics rising 2.1% to $5.84 on Friday while NASDAQ Composite slid 0.7% to $14,543.13.

Volume

Today’s last reported volume for Bionano Genomics is 12720200, 45.85% below its average volume of 23489200.

Bionano Genomics’s last close was $5.72, 63.54% below its 52-week high of $15.69.

Bionano Genomics’s Sales

Bionano Genomics’s sales growth is 197.8% for the current quarter and 91.3% for the next. The company’s growth estimates for the current quarter and the next is 55.6% and 37.5%, respectively.

Bionano Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 178.9%, now sitting on 10.53M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bionano Genomics’s stock is considered to be overbought (>=80).

Bionano Genomics’s Stock Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $5.84 at 08:34 EST, way under its 52-week high of $15.69 and way above its 52-week low of $0.47.

Bionano Genomics’s Moving Average

Bionano Genomics’s worth is way below its 50-day moving average of $7.05 and way under its 200-day moving average of $7.69.

More news about Bionano Genomics.

9. MicroVision (MVIS) – Premarket: 1.74%

NASDAQ Composite ended the session with MicroVision dropping 0.65% to $13.76 on Friday while NASDAQ Composite dropped 0.7% to $14,543.13.

Volume

Today’s last reported volume for MicroVision is 4348860, 83.45% below its average volume of 26281400.

MicroVision’s last close was $13.85, 50.54% below its 52-week high of $28.00.

The company’s growth estimates for the current quarter and the next is a negative 150% and a negative 100%, respectively.

MicroVision’s Revenue

Year-on-year quarterly revenue growth declined by 67.4%, now sitting on 2.1M for the twelve trailing months.

Volatility

MicroVision’s last week, last month’s, and last quarter’s current volatility was a positive 0.24%, a negative 1.92%, and a positive 7.52%, respectively.

MicroVision’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.76% (last week), 3.72% (last month), and 7.52% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MicroVision’s stock is considered to be overbought (>=80).

MicroVision’s Stock Yearly Top and Bottom Value

MicroVision’s stock is valued at $13.76 at 08:34 EST, way below its 52-week high of $28.00 and way above its 52-week low of $1.25.

MicroVision’s Moving Average

MicroVision’s value is way under its 50-day moving average of $18.08 and below its 200-day moving average of $14.33.

More news about MicroVision.

10. Zoom (ZM) – Premarket: 1.73%

NASDAQ Composite ended the session with Zoom dropping 1.05% to $356.81 on Friday, after five sequential sessions in a row of losses. NASDAQ Composite slid 0.7% to $14,543.13, after three sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Zoom is 2353670, 21.05% below its average volume of 2981060.

Zoom’s last close was $360.61, 38.76% under its 52-week high of $588.84.

The company’s growth estimates for the present quarter and the next is 26.1% and 10.1%, respectively.

Zoom’s Revenue

Year-on-year quarterly revenue growth grew by 191.4%, now sitting on 3.28B for the twelve trailing months.

Volatility

Zoom’s last week, last month’s, and last quarter’s current volatility was a negative 2.23%, a positive 0.06%, and a positive 1.78%, respectively.

Zoom’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.23% (last week), 1.61% (last month), and 1.78% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Zoom’s stock is considered to be overbought (>=80).

Zoom’s Stock Yearly Top and Bottom Value

Zoom’s stock is valued at $356.81 at 08:34 EST, way below its 52-week high of $588.84 and way higher than its 52-week low of $230.00.

Zoom’s Moving Average

Zoom’s worth is above its 50-day moving average of $356.06 and above its 200-day moving average of $352.77.

Previous days news about Zoom

Zoom video stock heads for 7th-straight loss after benchmark starts coverage at hold. According to MarketWatch on Thursday, 15 July, "Shares of Zoom Video Communications Inc. fell 0.9% in afternoon trading Thursday, and has now tumbled 10.7% amid a seven-day losing streak. ", "Harrigan said he acknowledges that the company "may defy skeptics" by boosting market share as it broadens its business through its increasingly successful Zoom Phone. "

More news about Zoom.

Most Active Premarket Losers Today

1. FibroGen (FGEN) – Premarket: -33.57%

NASDAQ Composite ended the session with FibroGen rising 1.02% to $24.84 on Friday, following the last session’s upward trend. NASDAQ Composite dropped 0.7% to $14,543.13, after three consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for FibroGen is 2146890, 109.16% above its average volume of 1026450.

FibroGen’s last close was $24.84, 56.58% below its 52-week high of $57.21.

News about FibroGen today

Astrazeneca and fibrogen face FDA red light over anaemia drug. According to today’s article on Proactive Investors, "Roxadustat is a partnership with FibroGen Inc (NASDAQ:FGEN), which first developed the drug.", "Although we are disappointed by today’s outcome, we will continue to work closely with our partner FibroGen and the FDA to determine the path forward for Roxadustat."

Astrazeneca says FDA advisory committee won’t support CKD treatment for approval, partner fibrogen stock plunges. According to today’s article on Market Watch, "Shares of FibroGen Inc. , which was AstraZeneca’s partner in developing roxadustat, plummeted 34.1% in premarket trading, while AstraZeneca’s U.S.-listed shares edged up 0.4%. ", "Although we are disappointed by today’s outcome, we will work closely with our partner FibroGen and the FDA to determine the path forward for roxadustat," said Mene Pangalos, executive vice president of BioPharmaceuticals R&D at AstraZeneca. "

Astrazeneca says FDA advisory committee won't support CKD treatment for approval, partner fibrogen stock plunges. According to today’s article on MarketWatch, "Shares of FibroGen Inc. , which was AstraZeneca’s partner in developing roxadustat, plummeted 34.1% in premarket trading, while AstraZeneca’s U.S.-listed shares edged up 0.4%. ", "Although we are disappointed by today’s outcome, we will work closely with our partner FibroGen and the FDA to determine the path forward for roxadustat," said Mene Pangalos, executive vice president of BioPharmaceuticals R&D at AstraZeneca. "

The company’s growth estimates for the ongoing quarter is 52.6% and a drop 60% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth grew by 57.5%, now sitting on 190.35M for the twelve trailing months.

Volatility

FibroGen’s last week, last month’s, and last quarter’s current volatility was a positive 0.47%, a negative 0.09%, and a positive 2.47%, respectively.

FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.30% (last week), 2.27% (last month), and 2.47% (last quarter), respectively.

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $24.84 at 08:34 EST, way below its 52-week high of $57.21 and way above its 52-week low of $18.12.

FibroGen’s Moving Average

FibroGen’s worth is under its 50-day moving average of $25.04 and way under its 200-day moving average of $32.41.

More news about FibroGen.

2. Catalyst Pharmaceuticals (CPRX) – Premarket: -5.8%

NASDAQ Composite ended the session with Catalyst Pharmaceuticals jumping 2.6% to $5.52 on Friday, after two successive sessions in a row of losses. NASDAQ Composite fell 0.7% to $14,543.13, after three consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Catalyst Pharmaceuticals is 800640, 35.87% below its average volume of 1248420.

Catalyst Pharmaceuticals’s last close was $5.38, 13.5% under its 52-week high of $6.22.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 120.14M for the twelve trailing months.

Volatility

Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a positive 1.47%, a negative 0.20%, and a positive 1.92%, respectively.

Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.47% (last week), 1.61% (last month), and 1.92% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be overbought (>=80).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $5.52 at 08:34 EST, way below its 52-week high of $6.22 and way above its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is below its 50-day moving average of $5.67 and way higher than its 200-day moving average of $4.60.

More news about Catalyst Pharmaceuticals.

3. ZoomInfo (ZI) – Premarket: -5.53%

NASDAQ Composite ended the session with ZoomInfo falling 1.8% to $49.75 on Friday while NASDAQ Composite fell 0.7% to $14,543.13.

Volume

Today’s last reported volume for ZoomInfo is 1396960, 18.73% below its average volume of 1718940.

ZoomInfo’s last close was $50.66, 15.96% under its 52-week high of $60.28.

ZoomInfo’s Sales

ZoomInfo’s sales growth is 53.8% for the present quarter and 39.8% for the next. The company’s growth estimates for the present quarter and the next is 71.4% and 9.1%, respectively.

ZoomInfo’s Revenue

Year-on-year quarterly revenue growth grew by 50%, now sitting on 527.3M for the twelve trailing months.

Volatility

ZoomInfo’s last week, last month’s, and last quarter’s current volatility was 0.68%, 0.88%, and 2.13%, respectively.

ZoomInfo’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.81% (last week), 1.64% (last month), and 2.13% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ZoomInfo’s stock is considered to be overbought (>=80).

ZoomInfo’s Stock Yearly Top and Bottom Value

ZoomInfo’s stock is valued at $49.75 at 08:34 EST, way below its 52-week high of $60.28 and way higher than its 52-week low of $30.83.

ZoomInfo’s Moving Average

ZoomInfo’s value is higher than its 50-day moving average of $48.40 and above its 200-day moving average of $48.71.

Previous days news about ZoomInfo

Zoominfo technologies using new financing to help pay for AI startup. According to The Wall Street Journal on Tuesday, 13 July, "About $225 million of this will be used to pay back a revolving credit facility that ZoomInfo drew down on for short-term funding of the deal.", "We feel that our sales force can use this and sell this alongside the ZoomInfo platform," Mr. Hyzer said. "

More news about ZoomInfo.

4. ImmunoGen (IMGN) – Premarket: -3.09%

NASDAQ Composite ended the session with ImmunoGen sliding 1.69% to $5.82 on Friday, after three sequential sessions in a row of losses. NASDAQ Composite slid 0.7% to $14,543.13, after three consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for ImmunoGen is 999989, 47.88% below its average volume of 1918480.

ImmunoGen’s last close was $5.92, 45.59% below its 52-week high of $10.88.

ImmunoGen’s Sales

ImmunoGen’s sales growth is 29.7% for the present quarter and 24.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 28.6% and a negative 53.8%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 134.72M for the twelve trailing months.

Volatility

ImmunoGen’s last week, last month’s, and last quarter’s current volatility was a positive 0.71%, a negative 0.22%, and a positive 2.44%, respectively.

ImmunoGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.35% (last week), 2.01% (last month), and 2.44% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ImmunoGen’s stock is considered to be overbought (>=80).

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $5.82 at 08:34 EST, way under its 52-week high of $10.88 and way above its 52-week low of $3.38.

ImmunoGen’s Moving Average

ImmunoGen’s worth is under its 50-day moving average of $6.36 and way below its 200-day moving average of $7.45.

More news about ImmunoGen.

5. Arcelor Mittal (MT) – Premarket: -2.28%

NYSE Composite ended the session with Arcelor Mittal jumping 0.84% to $31.15 on Friday, following the last session’s upward trend. NYSE Composite slid 0.27% to $16,499.06, after three sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for Arcelor Mittal is 3135110, 30.2% below its average volume of 4491320.

Arcelor Mittal’s last close was $30.89, 9.04% under its 52-week high of $33.96.

Arcelor Mittal’s Sales

Arcelor Mittal’s sales growth is 70.3% for the current quarter and 40.3% for the next. The company’s growth estimates for the present quarter and the next is 973.3% and 1915.8%, respectively.

Arcelor Mittal’s Revenue

Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 54.62B for the twelve trailing months.

Volatility

Arcelor Mittal’s last week, last month’s, and last quarter’s current volatility was a positive 0.90%, a negative 0.18%, and a positive 2.08%, respectively.

Arcelor Mittal’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.49% (last week), 2.17% (last month), and 2.08% (last quarter), respectively.

Arcelor Mittal’s Stock Yearly Top and Bottom Value

Arcelor Mittal’s stock is valued at $31.15 at 08:34 EST, below its 52-week high of $33.96 and way higher than its 52-week low of $10.71.

Arcelor Mittal’s Moving Average

Arcelor Mittal’s value is below its 50-day moving average of $31.32 and way higher than its 200-day moving average of $27.57.

More news about Arcelor Mittal.

6. Canaan (CAN) – Premarket: -2.22%

NASDAQ Composite ended the session with Canaan falling 3.23% to $6.30 on Friday while NASDAQ Composite fell 0.7% to $14,543.13.

Volume

Today’s last reported volume for Canaan is 4525500, 44.6% below its average volume of 8169140.

Canaan’s last close was $6.51, 83.35% below its 52-week high of $39.10.

Canaan’s Revenue

Year-on-year quarterly revenue growth grew by 489.9%, now sitting on 782.19M for the twelve trailing months.

Volatility

Canaan’s last week, last month’s, and last quarter’s current volatility was a negative 2.57%, a negative 2.50%, and a positive 6.23%, respectively.

Canaan’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.09% (last week), 4.38% (last month), and 6.23% (last quarter), respectively.

Canaan’s Stock Yearly Top and Bottom Value

Canaan’s stock is valued at $6.30 at 08:34 EST, way under its 52-week high of $39.10 and way above its 52-week low of $1.80.

Canaan’s Moving Average

Canaan’s value is way under its 50-day moving average of $8.54 and way below its 200-day moving average of $12.45.

More news about Canaan.

7. Rio Tinto (RIO) – Premarket: -1.87%

NYSE Composite ended the session with Rio Tinto rising 0.61% to $86.25 on Friday while NYSE Composite slid 0.27% to $16,499.06.

Volume

Today’s last reported volume for Rio Tinto is 1388360, 42.83% below its average volume of 2428460.

Rio Tinto’s last close was $85.73, 10.67% below its 52-week high of $95.97.

News about Rio Tinto today

Rio tinto output drops but metal prices buoyant. According to today’s article on Proactive Investors, "Shipments of iron dropped by 12% in the three months to June and Rio Tinto said it is struggling to get skilled staff due to COVID-19restrictions."

Rio Tinto’s Revenue

Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 44.61B for the twelve trailing months.

Volatility

Rio Tinto’s last week, last month’s, and last quarter’s current volatility was a positive 0.69%, a negative 0.06%, and a positive 1.56%, respectively.

Rio Tinto’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.18% (last week), 1.39% (last month), and 1.56% (last quarter), respectively.

Rio Tinto’s Stock Yearly Top and Bottom Value

Rio Tinto’s stock is valued at $86.25 at 08:34 EST, way below its 52-week high of $95.97 and way higher than its 52-week low of $55.39.

Rio Tinto’s Moving Average

Rio Tinto’s value is higher than its 50-day moving average of $85.64 and above its 200-day moving average of $83.51.

Previous days news about Rio Tinto

Burberry and rio tinto updates the key news for Friday. According to Proactive Investors on Thursday, 15 July, "Trading announcements: Rio Tinto PLC (LON:RIO), Burberry Group PLC (LON:BRBY), Eve Sleep PLC (LON:EVE)"

More news about Rio Tinto.

8. Riot Blockchain (RIOT) – Premarket: -1.67%

NASDAQ Composite ended the session with Riot Blockchain sliding 1.29% to $28.22 on Friday while NASDAQ Composite dropped 0.7% to $14,543.13.

Volume

Today’s last reported volume for Riot Blockchain is 4686150, 71.37% below its average volume of 16365600.

Riot Blockchain’s last close was $28.59, 64.04% below its 52-week high of $79.50.

The company’s growth estimates for the current quarter and the next is 112.9% and 650%, respectively.

Riot Blockchain’s Revenue

Year-on-year quarterly revenue growth grew by 872.2%, now sitting on 32.89M for the twelve trailing months.

Volatility

Riot Blockchain’s last week, last month’s, and last quarter’s current volatility was a negative 4.12%, a negative 0.49%, and a positive 5.42%, respectively.

Riot Blockchain’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.12% (last week), 2.93% (last month), and 5.42% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Riot Blockchain’s stock is considered to be overbought (>=80).

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $28.22 at 08:34 EST, way under its 52-week high of $79.50 and way higher than its 52-week low of $2.06.

Riot Blockchain’s Moving Average

Riot Blockchain’s value is way below its 50-day moving average of $32.16 and way below its 200-day moving average of $37.20.

More news about Riot Blockchain.

9. The Hershey Company (HSY) – Premarket: -1.58%

NYSE Composite ended the session with The Hershey Company jumping 1.08% to $179.49 on Friday while NYSE Composite fell 0.27% to $16,499.06.

Volume

Today’s last reported volume for The Hershey Company is 452769, 51.42% below its average volume of 932046.

The Hershey Company’s last close was $177.57, 0.44% under its 52-week high of $178.36.

The Hershey Company’s Sales

The Hershey Company’s sales growth is 5% for the current quarter and 5% for the next. The company’s growth estimates for the current quarter and the next is 9.2% and 5.9%, respectively.

The Hershey Company’s Revenue

Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 8.41B for the twelve trailing months.

Volatility

The Hershey Company’s last week, last month’s, and last quarter’s current volatility was 0.03%, 0.03%, and 0.63%, respectively.

The Hershey Company’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.37% (last week), 0.79% (last month), and 0.63% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

The Hershey Company’s stock is considered to be oversold (<=20).

The Hershey Company’s Stock Yearly Top and Bottom Value

The Hershey Company’s stock is valued at $179.49 at 08:34 EST, higher than its 52-week high of $178.36.

The Hershey Company’s Moving Average

The Hershey Company’s value is above its 50-day moving average of $173.65 and way higher than its 200-day moving average of $159.55.

More news about The Hershey Company.

10. Sun Communities (SUI) – Premarket: -1.54%

NYSE Composite ended the session with Sun Communities rising 0.8% to $182.82 on Friday while NYSE Composite fell 0.27% to $16,499.06.

Volume

Today’s last reported volume for Sun Communities is 253588, 42.98% below its average volume of 444734.

Sun Communities’s last close was $181.37, 0.23% higher than its 52-week high of $180.95.

The company’s growth estimates for the current quarter is a negative 1.7% and positive 1.3% for the next.

Sun Communities’s Revenue

Year-on-year quarterly revenue growth grew by 42.7%, now sitting on 1.51B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sun Communities’s stock is considered to be oversold (<=20).

Sun Communities’s Stock Yearly Top and Bottom Value

Sun Communities’s stock is valued at $182.82 at 08:34 EST, higher than its 52-week high of $180.95.

Sun Communities’s Moving Average

Sun Communities’s value is higher than its 50-day moving average of $172.70 and way above its 200-day moving average of $157.12.

More news about Sun Communities.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here